selegiline
Ligand Summary
A selective, irreversible inhibitor of Type B monoamine oxidase that is used for the treatment of newly diagnosed patients with PARKINSON DISEASE, and for the treatment of depressive disorders. The compound without isomeric designation is Deprenyl.
UNII: 2K1V7GP655
PubChem: 26757
PubChem: 26758
Guide to Pharmacology: 6639
ChEMBL: CHEMBL972
ChEMBL: CHEMBL1200904
DrugCentral: 2429
LyCHI: 4ZNCJ37XW31H
Target Activities
108 Activities
Items per page:
1 – 10 of 108
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||